The stock of Alkermes plc (NASDAQ:ALKS) decreased by -$0.04 on Tuesday to finish at $27.18, down -0.15 percent. The last five days have seen an average of 2,919,680 shares of common stock traded. 22 times new highs were reached in the current year, with a gain of $1.05. The average number of shares traded over the last 20 days was 2,012,715, while the average volume over the last 50 days totaled 1,769,164.
ALKS stock dropped -7.17% since last month. On 08/25/23, the company’s shares reached a one-month low of $25.68. The stock touched a high of $33.71 on 06/26/23, after rallying from a low of $21.75 in 52 weeks. The price of ALKS stock has risen by 4.02% or $1.05 this year, reaching a new high 22 times. Still, the stock price is down -19.37% from the 52-week high.
Insider Transactions
ALKS stock investors should be aware that Alkermes plc (ALKS) stock had its last reported insider trading activity 83 days ago on Jun 08. On Jun 08, Director LAURENCIN CATO T sold 2,638 shares at $31.85 each. This transaction resulted in the insider making $84,020. On Jun 07, LAURENCIN CATO T sold 2,800 shares at a price of US$31.50. After the transaction, the insider now owns 7,479 shares. SVP, Chief Commercial Officer Nichols Christian Todd had earlier sold 27,134 shares on May 30 for $28.93 a share. The transaction was completed for $784,862.
Valuation Metrics
Alkermes plc (ALKS) has a trailing price-to-earnings (P/E) ratio of 48.02. Beta for the stock is 0.61. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 3.14, the price-to-book (PB) ratio of 3.53, and the price-to-cash flow ratio of 28.88.
Financial Health
For the recent quarter, Alkermes plc’s quick ratio was 2.50, while its current ratio was 2.90, indicating its ability to pay off its debt. The company’s long-term debt to equity ratio for the recent quarter is 0.23, and the total debt to equity ratio is 0.23. As far as profitability goes, gross margin for the trailing twelve months is 84.50% percent. Alkermes plc’s EBITDA margin for the recent year was -5.79%, whereas its operating margin stood at 7.60% for the same period. Based on annual data, it had gross profit of $893.69 million and revenue of $1.11 billion.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. ALKS’s return on assets (ROA) during the last 12 months has been 5.10%. There was a -10.00% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was 9.40%.
Earnings Surprise
A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $617.4 million, while revenues rose by 55.26% to $287.6 million. EBITDA was $258.2 million for the quarter. At the end of Alkermes plc’s most recent quarter, its liabilities totaled 906.75 million, while its total debt was $389.54 million. Equity owned by shareholders amounts to $166.56 million.
Technical Picture
Here’s a quick look at Alkermes plc’s (ALKS) price momentum from a technical perspective. As of 29 August, the RSI 9-day stood at 31.52%, suggesting the stock is Neutral, with a 31.09% historical volatility rate.
The stochastic %K and %D were 35.87% and 27.08% respectively, while the average true range (ATR) was 0.84. Based on the 14-day stochastic reading of 35.63%, the RSI (14) reading is 35.11%. On the 9-day MACD Oscillator, the stock is at -1.05, and the 14-day reading is at -1.11.
Analyst Ratings
In its most recent analyst report, Piper Sandler raised its rating on Alkermes plc (NASDAQ: ALKS) to an Overweight. Prior to this, analysts firm rated the stock as a Neutral. Analysts have assigned Alkermes plc (ALKS) an Overweight rating. ALKS is a stock that is recommended for selling by 0 brokerage firms, while 5 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 0 rates it overweight and 5 others recommend it as a buy.
What is ALKS’s price target for the next 12 months?
The current consensus forecast for the stock is between $30.00 and $48.00, with a median target price of $36.00. In analyzing these forecasts, the average price target given by analysts for Alkermes plc (ALKS) is $36.67.
